V izpitnem obdobju dežurstev ni. Prosim, obrnite se na prodaja@medrazgl.si in info@medrazgl.si.
MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 2004 » 4 » | Archive » Medical field » Fields » Biochemistry » Archive » Medical field » Fields » Gynecology and Obstetrics »

The Role of Hydroxysteroid Dehydrogenases in the Regulation of Estrogen and Progestagen Activity: a Case of Endometrial Cancer and Endometriosis

 
Abstract:

This post is also available in: English Slovenščina (Slovenian)

Endometrial cancer and endometriosis are very common estrogen-dependent diseases. Endometrial cancer is the third most common cancer in women, while endometriosis affects around 15–20% of women of reproductive age and leads to infertility in 30–50% of patients. The current hypoth­esis postulates that exposure to estrogens unopposed by progestagens increases the mitotic activity of endometrial cells and the number of errors during DNA replication that can lead to hyper­plasia or a malignant phenotype. The activity of estrogens and progestagens is regulated at the receptor and pre-receptor levels, by interconversions between the active forms (estradiol, progesterone) and inactive forms (estrone, 20α-hydroxyprogesterone). The enzymes which are responsible for these interconversions are 17β-hydroxysteroid dehydrogenase and 20α-hydroxysteroid dehydrogenase. The difference in the expression of these enzymes in endometrial cancer and endometriosis may lead to high estrogen concentrations and low progestagen concentrations, which could result in the development of endometrial cancer or endometriosis.

Authors:
Tea Lanišnik Rižner, Jasna Šinkovec

Keywords:
endometrial neoplasms, endometriosis, hydroxysteroid dehydrogenases, estrogens, progestational hormones

Cite as:
Med Razgl. 2004; 43: 419–28.

Download PDF >>
© 2025 Društvo Medicinski razgledi | Na vrh strani / To top ↑